CONCERT PHARMACEUTICALS INC's ticker is and the CUSIP is 206022955. A total of 2 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $34,000 | +61.9% | 5,000 | 0.0% | 0.00% | – |
| Q2 2022 | $21,000 | +90.9% | 5,000 | +100.0% | 0.00% | – |
| Q2 2021 | $11,000 | +37.5% | 2,500 | +47.1% | 0.00% | – |
| Q1 2021 | $8,000 | -68.0% | 1,700 | -15.0% | 0.00% | – |
| Q4 2020 | $25,000 | +25.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2020 | $20,000 | -80.2% | 2,000 | -81.8% | 0.00% | -100.0% |
| Q4 2019 | $101,000 | -74.5% | 11,000 | -83.7% | 0.00% | -66.7% |
| Q3 2019 | $396,000 | -57.2% | 67,400 | -12.7% | 0.00% | -62.5% |
| Q2 2019 | $926,000 | +7023.1% | 77,200 | +7620.0% | 0.01% | – |
| Q4 2018 | $13,000 | -13.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2018 | $15,000 | +400.0% | 1,000 | +900.0% | 0.00% | – |
| Q4 2017 | $3,000 | 0.0% | 100 | -50.0% | 0.00% | – |
| Q3 2017 | $3,000 | -99.6% | 200 | -99.7% | 0.00% | -100.0% |
| Q2 2017 | $798,000 | +15860.0% | 57,200 | +18966.7% | 0.01% | – |
| Q1 2017 | $5,000 | -75.0% | 300 | -85.0% | 0.00% | – |
| Q3 2016 | $20,000 | -16.7% | 2,000 | -4.8% | 0.00% | – |
| Q2 2016 | $24,000 | +2300.0% | 2,100 | +2000.0% | 0.00% | – |
| Q1 2016 | $1,000 | -98.7% | 100 | -97.5% | 0.00% | -100.0% |
| Q4 2015 | $76,000 | +1.3% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $75,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,700 | $8,000 | 0.00% |
| SIMPLEX TRADING, LLC | 63 | $31,000 | 0.00% |